Covid-19 may be a risk factor for multiple sclerosis (MS). This has been shown by new research at örebro University and örebro University Hospital, Sweden.
Liver disease MASH is next target for obesity drugs in development
As drugmakers race to join the obesity drug market ignited by the approval of Wegovy and Zepbound, they’re not just competing on their drugs’ weight